The UK National Health Service has published a final report on the Poly Implant Prothèse (Pip) breast implants. The report was conducted by the NHS Medical Director Bruce Keogh’s expert group. It looked at the rupture rates and health effects of the Pip implants. The Pip implant scandal broke when it was revealed that the now-defunct French company had manufactured breast implants with industrial-grade silicone.
The report found that the implants have rupture rates about two times higher than that of typical breast implants and higher concentration of siloxanes. However, the implants don’t have any long-term health effects and are not toxic or carcinogenic, according to the report. When the implants rupture, some patients experience local reactions and symptoms such as tenderness. The Pip implant scandal may have caused patients to suffer from anxiety, however, which in itself is a health risk, the UK Department of Health notes in a press release.
The expert group studied information on 240,000 breast implants, which had been given to 130,000 patients. Bruce Keogh is also conducting a separate review on regulations for cosmetic interventions. In May, the UK Health Minister Lord Howe published a report that evaluated the actions of the UK Medicines and Healthcare products Regulatory Agency regarding the Pip implant scandal.Camilla Andersson